IBTR! 2.0: 10-year Ipsilateral Breast Tumor Recurrence - Evidencio
IBTR! 2.0: 10-year Ipsilateral Breast Tumor Recurrence
The Ipsilateral Breast Tumor Recurrence (IBTR) 2.0 is designed for use by physicians to guide medical decision-making regarding the use of radiation therapy in breast cancer patients who have undergone breast conserving surgery and appropriate axillary evaluation. This model calculates an evidence-based estimate of the 10-year ipsilateral breast tumor recurrence risk with and without the addition of whole breast radiation therapy. 

The IBTR 2.0 is not intended for use in the post-mastectomy setting, and it is not meant to address patients with multicentric disease or with in-situ only disease. It is assumed that all pathological specimens have been microscopically assessed with current histopathological standards. It is presumed that patients who are lymph node positive (with the exception of micrometastatic lymph node disease) will receive systemic therapy, either chemotherapy or hormonal therapy. The calculated benefit of hormonal therapy in this model is based on the tamoxifen literature and has been extrapolated to the use of aromatase inhibitors. Recent studies indicate that aromatase inhibitors have a similar, and possibly a slightly superior, impact on local control. 
Autores de la investigación: Mona Sanghani, Pauline T. Truong, Rita Abi Raad, Andrzej Niemierko, Mary Lesperance, Ivo A. Olivotto, David E. Wazer, Alphonse G. Taghian
Versión: 1.3
  • Público
  • Sin especificar
  • {{ modelType }}
  • Detalles
  • Guardar entrada
  • Entrada de carga
Mostrar
Unidades

Calcular el resultado

Establezca más parámetros para realizar el cálculo
Calculando......
Error de cálculo. Por favor, compruebe el algoritmo.

Información condicional

{{ file.classification }}
PRO
Nota
Las notas sólo son visibles en la descarga de resultados y no serán guardadas por Evidencio

Este algoritme se proporciona con fines educativos, formativos e informativos. No debe utilizarse para apoyar la toma de decisiones médicas ni para prestar servicios médicos o de diagnóstico. Lea nuestro Descargo de responsabilidad.

Algoritmer subyacentes Parte de
Comentarios
Comentario
Escriba un comentario
Los comentarios son visibles para cualquiera

Comentarios sobre el algoritme

Aún no hay comentarios 1 comentario {{ model.comments.length }} Comentarios
En {{ comment.created_at }} {{ comment.user.username }} un autor ya no registrado escribió:
{{ comment.content }}
Evidencio v3.38 © 2015 - 2025 Evidencio. Todos los derechos reservados